Get the Stockscreener App
0.97
3.00%
-0.03
Therapeuticsmd Inc Stock (TXMD) Forecast
The Therapeuticsmd Inc (TXMD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $91.20, representing a +9,302% increase from the current price of $0.97. The highest analyst price target is $89.06, and the lowest is $93.34.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TXMD Price Target
Average 54.98
(+5,568% Upside)
Is Therapeuticsmd Inc (TXMD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.92 | Neutral |
| STOCH(9,6) | 54.62 | Neutral |
| STOCHRSI(14) | 66.97 | Neutral |
| MACD(12,26) | 0.0166 | Buy |
| ADX(14) | 30.42 | Buy |
| William %R | -42.15 | Neutral |
| CCI(14) | 52.65 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9584
Buy
|
0.9486
Buy
|
| MA20 |
0.871
Buy
|
0.9228
Buy
|
| MA50 |
0.9542
Buy
|
0.9675
Buy
|
| MA100 |
1.1006
Sell
|
1.1077
Sell
|
| MA200 |
1.4021
Sell
|
1.3768
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, TXMD could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 4 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on TXMD, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.92 indicates that TXMD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 54.62 indicates that TXMD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.97 indicates that TXMD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.42 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 52.65 indicates that TXMD is still overbought but not to an extreme extent.
Long-term TXMD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Therapeuticsmd Inc financial reports and earnings history, Therapeuticsmd Inc (TXMD) stock could reach $177.29 by 2030, $113.52 by 2040 and $372.23 by 2050. See the projected annual prices until 2050 of the Therapeuticsmd Inc stock below:
- Therapeuticsmd Inc (TXMD) is expected to reach an average price of $32.85 in 2035, with a high prediction of $38.22 and a low estimate of $33.66. This indicates an $3,287% rise from the last recorded price of $0.97.
- Therapeuticsmd Inc (TXMD) stock is projected to chart a bullish course in 2040, with an average price target of $108.66, representing an $11,102% surge from its current level. The forecast ranges from a conservative $108.70 to a sky-high $113.52.
- Our analysts predict Therapeuticsmd Inc (TXMD) to jump 22,467% by 2045, soaring from $219.24 to an average price of $218.90, potentially reaching $223.09. While $219.24 is the low estimate, the potential upside is significant.
- Therapeuticsmd Inc (TXMD) stock is expected to climb by 2050, reaching an average of $355.53, a $36,552% jump from its current level. However, a wide range of estimates exists, with high and low targets of $372.23 and $363.12, respectively, highlighting the market's uncertainty.
Therapeuticsmd Inc Stock (TXMD) Year by Year Forecast
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2025
Therapeuticsmd Inc Stock (TXMD) is expected to reach an average price of $57.10 in 2025, with a high prediction of $89.06 and a low estimate of $25.15. This indicates an +5,787% rise from the last recorded price of $0.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $91.68 | $93.34 | $89.06 | +9,352% |
| June, 2025 | $78.05 | $71.20 | $69.05 | +7,946% |
| July, 2025 | $73.68 | $73.26 | $72.33 | +7,496% |
| August, 2025 | $56.39 | $63.89 | $70.04 | +5,714% |
| September, 2025 | $45.60 | $41.67 | $38.82 | +4,601% |
| October, 2025 | $55.73 | $51.45 | $51.05 | +5,646% |
| November, 2025 | $44.94 | $52.94 | $55.17 | +4,533% |
| December, 2025 | $60.08 | $43.30 | $46.58 | +6,093% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2026
The predicted value for Therapeuticsmd Inc (TXMD) in 2026 is set at an average of $37.90. Estimates vary from a peak of $54.90 to a trough of $20.91, indicating an +3,808% surge from the present price of $0.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $50.28 | $55.78 | $53.36 | +5,084% |
| February, 2026 | $55.99 | $53.21 | $53.99 | +5,672% |
| March, 2026 | $45.20 | $49.20 | $54.42 | +4,560% |
| April, 2026 | $22.83 | $20.91 | $34.62 | +2,254% |
| May, 2026 | $32.04 | $35.04 | $29.19 | +3,203% |
| June, 2026 | $40.75 | $40.32 | $38.39 | +4,101% |
| July, 2026 | $51.38 | $50.03 | $48.41 | +5,197% |
| August, 2026 | $35.59 | $42.09 | $40.81 | +3,569% |
| September, 2026 | $42.72 | $40.87 | $40.85 | +4,304% |
| October, 2026 | $48.74 | $47.00 | $45.43 | +4,925% |
| November, 2026 | $54.39 | $53.30 | $52.64 | +5,507% |
| December, 2026 | $54.11 | $54.96 | $54.90 | +5,479% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Therapeuticsmd Inc (TXMD) is $228.32, with a high forecast of $404.36 and a low forecast of $52.27. This indicates an +23,438% increase from the last price of $0.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $50.52 | $52.98 | $52.70 | +5,108% |
| February, 2027 | $58.28 | $52.27 | $54.94 | +5,908% |
| March, 2027 | $62.83 | $57.99 | $62.83 | +6,377% |
| April, 2027 | $64.27 | $63.73 | $62.23 | +6,526% |
| May, 2027 | $65.73 | $65.46 | $64.31 | +6,677% |
| June, 2027 | $65.86 | $66.02 | $65.28 | +6,690% |
| July, 2027 | $55.08 | $55.40 | $54.95 | +5,578% |
| August, 2027 | $60.66 | $55.91 | $56.79 | +6,153% |
| September, 2027 | $66.78 | $61.71 | $404.36 | +6,785% |
| October, 2027 | $56.75 | $56.83 | $58.36 | +5,750% |
| November, 2027 | $54.86 | $54.97 | $56.01 | +5,555% |
| December, 2027 | $52.26 | $52.72 | $56.29 | +5,288% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2028
In 2028, Therapeuticsmd Inc (TXMD) is projected to reach an average price of $38.85, with a high projection of $49.85 and a low estimate of $27.84. This indicates an +3,905% rise from the last price of $0.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $49.00 | $49.78 | $49.85 | +4,951% |
| February, 2028 | $50.24 | $50.48 | $49.47 | +5,080% |
| March, 2028 | $47.69 | $48.16 | $49.32 | +4,816% |
| April, 2028 | $47.27 | $47.40 | $46.99 | +4,773% |
| May, 2028 | $43.24 | $43.11 | $46.24 | +4,358% |
| June, 2028 | $41.08 | $41.32 | $42.54 | +4,135% |
| July, 2028 | $39.28 | $39.37 | $40.45 | +3,949% |
| August, 2028 | $37.53 | $37.16 | $38.35 | +3,769% |
| September, 2028 | $35.56 | $35.62 | $36.53 | +3,566% |
| October, 2028 | $33.00 | $33.53 | $34.74 | +3,302% |
| November, 2028 | $29.56 | $29.94 | $31.66 | +2,947% |
| December, 2028 | $27.55 | $27.84 | $28.89 | +2,740% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2029
The 2029 price forecast for Therapeuticsmd Inc Stock (TXMD) is $53.66 on average, with a high prediction of $106.73 and a low estimate of $0.584. This represents an +5,432% increase from the previous price of $0.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $24.74 | $24.80 | $26.77 | +2,451% |
| February, 2029 | $22.48 | $22.84 | $23.88 | +2,217% |
| March, 2029 | $20.89 | $20.89 | $21.91 | +2,053% |
| April, 2029 | $19.38 | $19.57 | $20.17 | +1,898% |
| May, 2029 | $17.06 | $17.06 | $18.56 | +1,659% |
| June, 2029 | $14.03 | $14.17 | $16.07 | +1,346% |
| July, 2029 | $12.22 | $12.25 | $13.57 | +1,160% |
| August, 2029 | $9.3476 | $9.3476 | $11.54 | +863.67% |
| September, 2029 | $7.0651 | $7.0951 | $8.7045 | +628.36% |
| October, 2029 | $4.1594 | $4.2394 | $6.3341 | +328.81% |
| November, 2029 | $2.2969 | $2.2969 | $3.5363 | +136.79% |
| December, 2029 | $168.48 | $0.584 | $106.73 | +17,269% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2030
Therapeuticsmd Inc Stock (TXMD) is expected to reach an average price of $180.85 in 2030, with a high forecast of $229.62 and a low forecast of $132.07. This signifies an +18,544% surge from the last price of $0.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $213.00 | $179.58 | $177.29 | +21,859% |
| February, 2030 | $204.91 | $206.41 | $196.46 | +21,025% |
| March, 2030 | $223.92 | $219.02 | $215.33 | +22,984% |
| April, 2030 | $178.74 | $190.99 | $176.74 | +18,327% |
| May, 2030 | $133.26 | $136.51 | $174.35 | +13,638% |
| June, 2030 | $170.42 | $132.07 | $128.87 | +17,469% |
| July, 2030 | $167.20 | $176.34 | $166.70 | +17,137% |
| August, 2030 | $186.36 | $182.05 | $174.90 | +19,112% |
| September, 2030 | $179.78 | $181.17 | $177.53 | +18,434% |
| October, 2030 | $166.04 | $170.29 | $162.19 | +17,018% |
| November, 2030 | $214.96 | $190.65 | $201.40 | +22,061% |
| December, 2030 | $236.09 | $232.40 | $229.62 | +24,240% |
9.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):